2010年至2020年美国商业保险人群中新门诊长效可逆避孕插入的发生率。

Q2 Medicine

Contraception: X Pub Date : 2023-01-01 DOI:10.1016/j.conx.2023.100101

Clara E. Busse , Chase D. Latour , Sara Z. Dejene , Andrea K. Knittel , Mollie E. Wood , Alan C. Kinlaw , Mekhala V. Dissanayake

{"title":"2010年至2020年美国商业保险人群中新门诊长效可逆避孕插入的发生率。","authors":"Clara E. Busse , Chase D. Latour , Sara Z. Dejene , Andrea K. Knittel , Mollie E. Wood , Alan C. Kinlaw , Mekhala V. Dissanayake","doi":"10.1016/j.conx.2023.100101","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>Characterize new use of long-acting reversible contraceptives (LARCs), highly effective contraceptive methods, in a broad population over time.</p></div><div><h3>Study Design</h3><p>We constructed a retrospective cohort of commercially insured individuals aged 15 to 54 years from 2010 to 2020 and estimated monthly incidence of new LARC insertions.</p></div><div><h3>Results</h3><p>The monthly standardized incidence increased from 6.0 insertions per 10,000 individuals in January 2010 to 14.1 in December 2020, with a dip in insertions after March 2020. Hormonal intrauterine devices were consistently the most inserted LARC; implants were increasingly favored over time.</p></div><div><h3>Conclusions</h3><p>LARCs are increasingly popular forms of contraception among commercially insured individuals.</p></div><div><h3>Implications</h3><p>Given the increasing popularity, ensuring access to LARCs is critical.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"5 ","pages":"Article 100101"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/3c/main.PMC10562738.pdf","citationCount":"0","resultStr":"{\"title\":\"Incidence of new outpatient long-acting reversible contraceptive insertions among a commercially insured, US population from 2010 to 2020\",\"authors\":\"Clara E. Busse , Chase D. Latour , Sara Z. Dejene , Andrea K. Knittel , Mollie E. Wood , Alan C. Kinlaw , Mekhala V. Dissanayake\",\"doi\":\"10.1016/j.conx.2023.100101\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><p>Characterize new use of long-acting reversible contraceptives (LARCs), highly effective contraceptive methods, in a broad population over time.</p></div><div><h3>Study Design</h3><p>We constructed a retrospective cohort of commercially insured individuals aged 15 to 54 years from 2010 to 2020 and estimated monthly incidence of new LARC insertions.</p></div><div><h3>Results</h3><p>The monthly standardized incidence increased from 6.0 insertions per 10,000 individuals in January 2010 to 14.1 in December 2020, with a dip in insertions after March 2020. Hormonal intrauterine devices were consistently the most inserted LARC; implants were increasingly favored over time.</p></div><div><h3>Conclusions</h3><p>LARCs are increasingly popular forms of contraception among commercially insured individuals.</p></div><div><h3>Implications</h3><p>Given the increasing popularity, ensuring access to LARCs is critical.</p></div>\",\"PeriodicalId\":10655,\"journal\":{\"name\":\"Contraception: X\",\"volume\":\"5 \",\"pages\":\"Article 100101\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/3c/main.PMC10562738.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Contraception: X\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590151623000138\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contraception: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590151623000138","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

目的：随着时间的推移，描述长效可逆避孕药（LARC）这一高效避孕方法在广泛人群中的新用途。研究设计：我们构建了一个回顾性队列，从2010年到2020年，年龄在15至54岁之间的商业保险个人，并估计了新的LARC插入的月发生率。结果：每月标准化发病率从2010年1月的每10000人6.0次插入增加到2020年12月的14.1次，2020年3月后插入次数有所下降。激素宫内节育器始终是插入LARC最多的；随着时间的推移，植入物越来越受欢迎。结论：LARC在商业保险个人中越来越流行。影响：鉴于越来越受欢迎，确保获得LARC至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Incidence of new outpatient long-acting reversible contraceptive insertions among a commercially insured, US population from 2010 to 2020

查看原文本刊更多论文

Incidence of new outpatient long-acting reversible contraceptive insertions among a commercially insured, US population from 2010 to 2020

Objectives

Characterize new use of long-acting reversible contraceptives (LARCs), highly effective contraceptive methods, in a broad population over time.

Study Design

We constructed a retrospective cohort of commercially insured individuals aged 15 to 54 years from 2010 to 2020 and estimated monthly incidence of new LARC insertions.

Results

The monthly standardized incidence increased from 6.0 insertions per 10,000 individuals in January 2010 to 14.1 in December 2020, with a dip in insertions after March 2020. Hormonal intrauterine devices were consistently the most inserted LARC; implants were increasingly favored over time.